Comera Life Announces Bridge Financing and Exercise of Take Private Option
04 Jan 2024 //
GLOBENEWSWIRE
Comera Life Sciences Announces Process Exploring Strategic Alternatives
06 Dec 2023 //
GLOBENEWSWIRE
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
13 Nov 2023 //
GLOBENEWSWIRE
Comera Life Sciences Reports Financial Results for Third Quarter 2023
09 Nov 2023 //
GLOBENEWSWIRE
Comera Life Sciences Presents SQore Platform Technology Data
16 Oct 2023 //
GLOBENEWSWIRE
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
12 Sep 2023 //
GLOBENEWSWIRE
Comera Announces Publication of Study Reinforcing Caffeine`s Viscosity Reducing Capabilities
16 Aug 2023 //
GLOBENEWSWIRE
Comera Life Sciences Reports Financial Results for Second Quarter 2023
10 Aug 2023 //
GLOBENEWSWIRE
Comera Life Sciences Expands Intellectual Property Portfolio
08 Aug 2023 //
GLOBENEWSWIRE
Comera Life Sciences Announces $4.1 Million Private Placement
01 Aug 2023 //
GLOBENEWSWIRE
Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories
20 Jul 2023 //
GLOBENEWSWIRE
Comera Life Sciences Reports Financial Results for First Quarter
11 May 2023 //
GLOBENEWSWIRE
Comera Life Sciences to Participate in Four Upcoming Conferences
27 Apr 2023 //
GLOBENEWSWIRE
Comera Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
03 Apr 2023 //
GLOBENEWSWIRE
Comera Life Reports Financial Results for Fourth Quarter and Full Year 2022
16 Mar 2023 //
GLOBENEWSWIRE
Comera Life Sciences to Present at 22nd Annual PepTalk Conference
12 Jan 2023 //
GLOBENEWSWIRE
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference
05 Jan 2023 //
GLOBENEWSWIRE
Comera Life Closes $3.6 Million Private Placement Priced under Nasdaq Rules
04 Jan 2023 //
GLOBENEWSWIRE
Comera Life to Participate in the Benchmark Company’s Upcoming Discovery
17 Nov 2022 //
GLOBENEWSWIRE
Comera Life Sciences Reports Financial Results for 3Q 2022 and Highlights
10 Nov 2022 //
GLOBENEWSWIRE
Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer
09 Nov 2022 //
GLOBENEWSWIRE
Comera Announces Favorable Results of Lead SQore Excipient in SEQURUS-2
18 Oct 2022 //
GLOBENEWSWIRE
Comera Life Sciences Expands Woburn Operations
04 Oct 2022 //
GLOBENEWSWIRE
Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena
31 Aug 2022 //
GLOBENEWSWIRE
Comera Life Sciences to Present Topline Results of SEQURUS-2 Study
11 Aug 2022 //
GLOBENEWSWIRE
Comera Life Sciences Provides Business Highlights and Reports for the Q2
10 Aug 2022 //
GLOBENEWSWIRE
Comera Life Sciences Announces Issuance of U.S Patent for Proprietary Excipients
22 Jun 2022 //
BUSINESSWIRE
Comera Life Sciences Appoints Michael Campbell as Executive VP and CFO
16 Jun 2022 //
BUSINESSWIRE
Comera Life Sciences Signs Research Collaboration with Top 10 Pharma Company
09 May 2022 //
BUSINESSWIRE
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
27 Apr 2022 //
BUSINESSWIRE